Stockhub

Anatara Lifesciences Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

18 August 2022

  • curprev 10:5210:52, 18 August 2022 >Paris 895 bytes +895 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome (..."
Retrieved from "https://stockhub.co/research/Anatara_Lifesciences_Limited"